Similar Articles
1691 Rab23 is a potential biological target for treating hepatocellular carcinoma
1692 Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma
1693 p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro
1694 Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation
1695 Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States
1696 A case of biliary gastric fistula following percutaneous radiofrequency thermal ablation of hepatocellular carcinoma
1697 Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran
1698 Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma
1699 Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
1700 New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA